Trimas Corp Dossier
|
SectorConsumer Discretionary IndustryPackaging & Containers Beta (adjusted)0.73 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $38.59Price as of 30 Sep 2026 Data confidenceNot applicable Market Cap $1.4B Enterprise Value $614.9M Shares Outstanding 38.6M diluted Moat Rating None Next Earnings Date29 Oct 2026 Last ex-dividend6 Aug 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary TriMas Corporation has successfully transformed its business profile by divesting its Aerospace segment in March 2026 for $1.2 billion in net proceeds, leaving the company with a robust net cash position of $913 million. Under the new leadership of CEO Thomas Snyder, who brings nearly 35 years of packaging industry experience, TriMas is uniquely positioned to accelerate growth and margin expansion in its core Packaging and Specialty Products platforms. The company's strong balance sheet provides substantial flexibility for strategic bolt-on acquisitions and aggressive share repurchases, while its operational realignment is on track to deliver significant structural cost savings. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$45.00 Mean target$45.00 High · most bullish analyst$45.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $45.00 The bear case reflects potential integration delays of recent acquisitions, prolonged customer destocking in industrial closures and cylinder products, and persistent inflationary pressures on raw materials like resins and steel. Slow capital deployment of cash proceeds limits EPS accretion, keeping the stock near its lower valuation floor. Base CaseCentral scenario $45.00 Matches the consensus meanThe base case is built on TriMas achieving its reaffirmed 2026 outlook of 3% to 6% sales growth and more than 300 basis points of adjusted operating profit margin expansion. Steady organic demand in beauty, personal care, and life sciences packaging, combined with interest income from divestiture proceeds and disciplined cost management, supports adjusted diluted EPS of $1.50 to $1.70. Bull CaseUpside scenario $45.00 The bull case assumes rapid deployment of the $913 million cash pile into high-margin packaging and life sciences acquisitions, coupled with accelerated share repurchases that significantly reduce the share count. Operational efficiencies and volume leverage drive operating margin expansion beyond the targeted 300 basis points, pushing adjusted EPS above the high end of guidance. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |